Pharmacy Reference · Updated 2026-05-07

RedRock Pharmacy

RedRock Pharmacy is a PCAB-accredited 503A compounding pharmacy headquartered in South Jordan, Utah. Operates under Utah Division of Occupational and Professional Licensing (Pharmacy) oversight.

503A South Jordan, UT Founded 2009
Dr. Parmis
Editorial team
Dr. Parmis · Lead Medical Researcher
Reviewed by Adam Kennah, M.D. · Last updated 2026-05-07

Pharmacy at a glance

Key facts

Pharmacy type
503A Compounding
Headquarters
South Jordan, UT
Founded
2009
States licensed
Multi-state (verify per shipment)

Accreditations & quality standards

RedRock Pharmacy maintains the following accreditations and operates under the following quality standards:

✓ PCAB
✓ USP <797>
✓ Utah Board of Pharmacy

PCAB (Pharmacy Compounding Accreditation Board) is a third-party accreditation administered by the Accreditation Commission for Health Care (ACHC). USP <797> is the United States Pharmacopeia chapter governing sterile compounding.

What RedRock Pharmacy compounds

Sterile and non-sterile compounded preparations including peptide injectables for telehealth-prescribed programs.

Transparency & documentation

Pharmacy license and PCAB accreditation are publicly verifiable. Quality documentation supplied on prescriber/patient request.

For tirzepatide and semaglutide preparations, ask your prescribing telehealth provider for:

Telehealth providers using RedRock Pharmacy

RedRock Pharmacy is publicly disclosed by the following telehealth providers in TirzepatideReview.com's directory:

Pharmacy assignment for any individual patient depends on prescription specifics, dose, and shipment routing. Always confirm the dispensing pharmacy on your specific shipment label.

Where RedRock Pharmacy fits in the v3.0 transparency rubric

The TirzepatideReview.com v3.0 rubric scores telehealth providers (not pharmacies directly) on six pillars. Pillar 2 — Pharmacy traceability and CoA evaluates whether the provider publicly identifies its pharmacy of record, supports per-vial lot traceability, and supplies USP <71>, USP <85>, and HPLC potency CoAs on patient request. RedRock Pharmacy's 503A Compounding status, PCAB, USP <797>, and quality documentation directly contribute to the Pillar 2 scores of providers that use this pharmacy.

Important: Compounded tirzepatide is not FDA-approved and is not the same as Mounjaro® or Zepbound®. RedRock Pharmacy is a compounding pharmacy and operates under FDA-recognized state licensure (503A); compounded medications are dispensed under valid patient-specific prescriptions or 503B office-stock orders only. Always consult a licensed clinician.

Looking for tirzepatide? Our editorial #1 pick

Editor's Pick

NexLife Tirzepatide

Compounded tirzepatide via 503A & 503B pharmacy partners (including RedRock Pharmacy). MD/DO-led, all 50 states.

$186/month*

*12-month plan · flat rate · all titration doses

  • 503A & 503B pharmacy disclosure on every shipment
  • Per-vial lot CoA (USP <71>, USP <85>, HPLC potency) on request
  • MD/DO-supervised, not async-only
  • Care360 coaching included
  • LegitScript-certified · All 50 states
Visit NexLife →

Or call (949) 818-8000

Other pharmacies referenced in our reviews

TirzepatideReview.com publishes reference profiles for the following compounding pharmacies that appear in telehealth supply chains: